Microviable Therapeutics SL
6 News & Press Releases found

Microviable Therapeutics SL news

As part of our growth and consolidation as a microbiome company focused on therapeutics we have several openings to join our team! Are you ready to rock?

Check out our careers section and submit your credentials: Microviable careers



Apr. 2, 2022

It is always a pleasure to work with prestigious researchers. Congratulations Alejandro Lucia! for the award received.

A group of ten researchers from various institutions, including Alejandro Lucia, a researcher at the European University and a Microviable collaborator, have received the Cajastur Foundation National Research Award in Sports Medicine, convened by the University of Oviedo, for their study that analyzes the consequences of the practice of high-performance endurance spor

May. 4, 2022

Last week, the Nature Group Scientific Reports journal published the top 100 most downloaded cell and molecular biology papers. This comprehensive list featured an outstanding
Mar. 1, 2022

Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL.

Microviable will use the seed funding to enhance their therapeutic development platf

Apr. 1, 2022

Microviable Therapeutics SL (Gijón, Asturias, Spain), announced a contractual agreement with BCD Bioscience Inc. (California, USA) to work on microbial fermentation and novel prebiotics to modulate the human gut microbiome.

Microviable expertise on gut microbiome research will enable to conveniently process microbiota samples for fermentation applications that co

Mar. 1, 2022

Contact supplier

Drop file here or browse